Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin for Prevention of Contrast-Induced Nephropathy in CKD
NCT01197235Phase 3Terminated
- Sponsor
- Seoul National University Bundang Hospital
- Start
- May 2009
- Primary completion
- Dec 2015
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 3 trial of darbepoetin alfa in contrast-induced nephropathy (CIN), sponsored by Seoul National University Bundang Hospital. Started May 2009; status: terminated.
02
Drugs
darbepoetin alfa
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT01197235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01197235.